Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial

The American Journal of Psychiatry
Sabine WilhelmLee Baer

Abstract

The authors investigated the efficacy of habit reversal for Tourette's disorder, which is characterized by multiple motor and vocal tics. Thirty-two patients with Tourette's disorder were randomly assigned to 14 sessions of either habit reversal or supportive psychotherapy. Habit reversal consisted of awareness training, self-monitoring, relaxation training, competing response training, and contingency management. Changes in severity of Tourette's disorder and psychosocial impairment were investigated over the course of the 14-session treatment for the 29 patients who completed at least eight treatment sessions. In contrast to the 13 patients in the supportive psychotherapy group, the 16 patients in the habit reversal group improved significantly. The habit reversal patients remained significantly improved over pretreatment at 10-month follow-up. Habit reversal may be an effective behavioral treatment for Tourette's disorder.

Associated Clinical Trials

Sep 14, 2007·Angeli Landeros-Weisenberger, Angeli Landeros-Weisenberger

Citations

Aug 8, 2012·Archives of General Psychiatry·Sabine WilhelmLawrence Scahill
May 21, 2010·JAMA : the Journal of the American Medical Association·John PiacentiniJohn T Walkup
Dec 7, 2005·Journal of Neurology·Liborio RampelloFrancesco Nicoletti
Feb 8, 2008·European Child & Adolescent Psychiatry·Yann PoncinLawrence Scahill
Feb 8, 2008·European Child & Adolescent Psychiatry·Manfred Döpfner, Aribert Rothenberger
Jul 17, 2008·Current Psychiatry Reports·Michael H Bloch
May 7, 2013·Current Treatment Options in Neurology·Daryl J Wile, Tamara M Pringsheim
Mar 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Lawrence ScahillJohn Walkup
Feb 22, 2005·Lancet Neurology·Harvey S Singer
Feb 2, 2012·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Joseph Brand, Dean McKay
Aug 26, 2009·Journal of Child and Adolescent Psychopharmacology·Tanya K MurphyMark Yang
Dec 18, 2012·Neuromodulation : Journal of the International Neuromodulation Society·Fabián PiedimonteOsvaldo Vilela Filho
Jan 11, 2005·Postgraduate Medical Journal·J S SternM M Robertson
Mar 30, 2011·European Child & Adolescent Psychiatry·Cara VerdellenUNKNOWN ESSTS Guidelines Group
Aug 26, 2014·The Psychiatric Clinics of North America·Adam B LewinEric A Storch
Dec 3, 2014·Psychiatry Research·Thilo DeckersbachSabine Wilhelm
Mar 29, 2011·Child and Adolescent Psychiatric Clinics of North America·Christopher A Flessner
Mar 5, 2016·Current Neurology and Neuroscience Reports·Aysegul Gunduz, Michael S Okun
Apr 4, 2007·Revue neurologique·R DialloL Mallet
Oct 17, 2007·Brain & Development·Paul J Lombroso, Lawrence Scahill
Aug 2, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·James E SwainJames F Leckman
Jan 5, 2010·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Jan FrölichManfred Döpfner
Jan 12, 2007·Journal of Psychiatric Research·Antje BohneSabine Wilhelm
Nov 7, 2015·Current Developmental Disorders Reports·Joseph F McGuireAdam B Lewin
Jan 27, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·David Shprecher, Roger Kurlan
May 23, 2006·Journal of Child Psychology and Psychiatry, and Allied Disciplines·James F LeckmanAribert Rothenberger
Jun 21, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Rizma Jalees BajwaJames F Leckman
Sep 23, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Jonathan W MinkUNKNOWN Tourette Syndrome Association, Inc
Jun 23, 2005·Pharmacology & Therapeutics·Neal R Swerdlow, Ashley N Sutherland
Oct 28, 2011·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Katrin Woitecki, Manfred Döpfner
Jun 19, 2012·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Veit RoessnerAribert Rothenberger
May 30, 2015·Pediatric Clinics of North America·Fatema J Serajee, A H M Mahbubul Huq
Oct 24, 2012·Neuroscience and Biobehavioral Reviews·J M T M van de GriendtM J P M Verbraak
Jan 9, 2014·Journal of Psychiatric Research·Joseph F McGuireEric A Storch
Sep 15, 2006·Journal of Child Neurology·James F LeckmanRobert A King
Sep 15, 2006·Journal of Child Neurology·Michael B HimleJohn T Walkup
Jun 6, 2009·Journal of Child Neurology·Nanette M M M DebesLiselotte Skov
Mar 8, 2011·British Journal of Hospital Medicine·Mary M Robertson

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.